Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 28;4:25.
doi: 10.1186/1756-0500-4-25.

Prevalence of Acanthosis Nigricans in an Urban Population in Sri Lanka and Its Utility to Detect Metabolic Syndrome

Free PMC article

Prevalence of Acanthosis Nigricans in an Urban Population in Sri Lanka and Its Utility to Detect Metabolic Syndrome

Anuradha S Dassanayake et al. BMC Res Notes. .
Free PMC article


Background: Insulin resistance (IR) plays a major role in the pathogenesis of metabolic syndrome. Acanthosis nigricans (AN) is an easily detectable skin condition that is strongly associated with IR. The aims of this study were, firstly, to investigate the prevalence of AN among adults in an urban Sri Lankan community and secondly, to describe its utility to detect metabolic syndrome.

Findings: In a community based investigation, 35-64 year adults who were selected using stratified random sampling, underwent interview, clinical examination, liver ultrasound scanning, and biochemical and serological tests. Metabolic syndrome was diagnosed on revised ATP III criteria for Asian populations. AN was identified by the presence of dark, thick, velvety skin in the neck.2957 subjects were included in this analysis. The prevalence of AN, metabolic syndrome and type 2 diabetes mellitus were 17.4%, 34.8% and 19.6%, respectively. There was a strong association between AN and metabolic syndrome. The sensitivity, specificity, positive predictive value and negative predictive value of AN to detect metabolic syndrome were 28.2%, 89.0%, 45.9% and 79.0% for males, and 29.2%, 88.4%, 65.6% and 62.3% for females, respectively.

Conclusions: AN was common in our study population, and although it did not have a high enough sensitivity to be utilized as a screening test for metabolic syndrome, the presence of AN strongly predicts metabolic syndrome.


Figure 1
Figure 1
A patient with acanthosis nigricans from the study.

Similar articles

See all similar articles

Cited by 4 articles


    1. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999;22(10):1655–9. doi: 10.2337/diacare.22.10.1655. - DOI - PubMed
    1. Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila) 1998;37(2):73–9. doi: 10.1177/000992289803700203. - DOI - PubMed
    1. Stuart CA, Smith MM, Gilkson CR, Shaheb S, Stahn RM. Acanthosis nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health. 1994;84:1839–42. doi: 10.2105/AJPH.84.11.1839. - DOI - PMC - PubMed
    1. Gilkson C, Stuart CA. Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinaemia, insulin resistance and diabetes risk. Nurse Pract. 1992;17:26–44. - PubMed
    1. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269–72. doi: 10.1016/S0002-9343(89)80149-4. - DOI - PubMed

LinkOut - more resources